Amgen AMGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.82B+5.1% | $1.33B+113% | $3.22B+13.6% | $1.43B+92.0% | $1.73B+1,631% | ||
| $1.12B-19.5% | $1.13B-19.0% | $1.31B-6.4% | $1.34B-4.2% | $1.39B-0.9% | ||
| $75M-11.8% | $125M-6.7% | $127M-6.6% | $157M0.0% | $85M-17.5% | ||
| $2.19B+57.4% | $1.6B-66.4% | $4.68B+31.2% | $2.28B-7.3% | $1.39B+102% | ||
| $712M+73.2% | $642M+73.0% | $436M+69.6% | $369M+55.0% | $411M+78.7% | ||
| -$716M-60.2% | -$693M-72.4% | -$414M-97.1% | -$389M-79.3% | -$447M-106% | ||
| $1.36B+6.2% | $1.28B+6.5% | $1.28B+6.0% | $1.28B+5.9% | $1.28B+5.9% | ||
| $3.96B— | —— | —— | —— | $0— | ||
| $833M-66.7% | $0— | $1.5B-31.8% | $1B-28.6% | $2.5B— | ||
| $1.44B+135% | -$1.23B+12.9% | -$2.85B+21.9% | -$2.67B-0.9% | -$4.11B-140% | ||
| $2.91B+192% | -$316M-111% | —— | -$782M-92.1% | -$3.16B-156% | ||
| $1.48B+50.7% | $961M-78.2% | $4.25B+28.2% | $1.91B-14.0% | $980M+114% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amgen generate?
- Amgen (AMGN) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Amgen's free cash flow?
- After $2.2B of capital expenditures, Amgen's free cash flow was $8.6B over the trailing twelve months, down 21.2% year over year.
- Where does Amgen's cash flow data come from?
- Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
